We've found
10,106 Gastrointestinal
clinical trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Other Clinical Trial
Vitamin D Deficiency and Dysautonomia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Biliary Atresia Clinical Trial
Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia
Status: Enrolling,
Phase
Updated: 3/5/2018
Click here to add this to my saved trials
Biliary Atresia Clinical Trial
Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia
Status: Enrolling,
Phase
Updated: 3/5/2018
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Orthopedics / Podiatry Clinical Trial
A Physical Activity Program in End-state Liver Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diverticulitis Clinical Trial
DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Status: Enrolling,
Phase
II, III
Updated: 1/25/2018
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pyloric Stenosis Clinical Trial
Institutional Audit of the Use of Intravenous Acetaminophen in Infants Undergoing Pyloromyotomy
Status: Enrolling
Updated: 3/8/2016
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
UNC Barrett's Esophagus and Esophageal Cancer Biorepository
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
End Stage Liver Disease Clinical Trial
Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies
Status: Enrolling
Updated: 1/12/2016
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Barrett Esophagus Clinical Trial
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
Status: Enrolling
Updated: 4/25/2018
Click here to add this to my saved trials
Opioid Addiction Clinical Trial
Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence
Status: Enrolling,
Phase
III
Updated: 4/11/2018
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
10,106 Gastrointestinal
clinical trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Clinical Trial
Updated: 12/31/1969
Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Other Clinical Trial
Updated: 12/31/1969
Vitamin D Deficiency and Dysautonomia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Biliary Atresia Clinical Trial
Updated: 3/5/2018
Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia
Status: Enrolling,
Phase
Updated: 3/5/2018
Click here to add this to my saved trials
Biliary Atresia Clinical Trial
Updated: 3/5/2018
Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia
Status: Enrolling,
Phase
Updated: 3/5/2018
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Updated: 12/31/1969
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Updated: 12/31/1969
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Updated: 12/31/1969
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Updated: 12/31/1969
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Updated: 12/31/1969
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Updated: 12/31/1969
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis and Crohn's Disease Clinical Trial
Updated: 12/31/1969
Entyvio (Vedolizumab) Long Term Safety Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
A Physical Activity Program in End-state Liver Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diverticulitis Clinical Trial
Updated: 12/31/1969
DEBUT: Diverticulitis Evaluation of Patient Burden, Utilization, and Trajectory
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
Updated: 12/31/1969
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Liver Failure Clinical Trial
Updated: 12/31/1969
13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 1/25/2018
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
Status: Enrolling,
Phase
II, III
Updated: 1/25/2018
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
Updated: 12/31/1969
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
Updated: 12/31/1969
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
Updated: 12/31/1969
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
T Cells Expressing a Fully-Human Anti-CD30 Chimeric Antigen Receptor for Treating CD30-Expressing Lymphomas
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Updated: 12/31/1969
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Pyloric Stenosis Clinical Trial
Updated: 3/8/2016
Institutional Audit of the Use of Intravenous Acetaminophen in Infants Undergoing Pyloromyotomy
Status: Enrolling
Updated: 3/8/2016
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
UNC Barrett's Esophagus and Esophageal Cancer Biorepository
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
End Stage Liver Disease Clinical Trial
Updated: 1/12/2016
Procurement of Leukapheresis Products From End Stage Liver Disease (ESLD) Patients for Immunological Studies
Status: Enrolling
Updated: 1/12/2016
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Barrett Esophagus Clinical Trial
Updated: 4/25/2018
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
Status: Enrolling
Updated: 4/25/2018
Click here to add this to my saved trials
Opioid Addiction Clinical Trial
Updated: 4/11/2018
Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence
Status: Enrolling,
Phase
III
Updated: 4/11/2018
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials